LEADING LABORATORY QUALITY

LEADING LABORATORY QUALITY

LEADING LABORATORY QUALITY

PATIENTS AROUND THE WORLD CAN TRUST THE INTEGRITY OF THEIR LABORATORY RESULTS BECAUSE OF THE CAP’S COMMITMENT TO QUALITY.

PATIENTS AROUND THE WORLD CAN TRUST THE INTEGRITY OF THEIR LABORATORY RESULTS BECAUSE OF THE CAP’S COMMITMENT TO QUALITY.

PATIENTS AROUND THE WORLD CAN TRUST THE INTEGRITY OF THEIR LABORATORY RESULTS BECAUSE OF THE CAP’S COMMITMENT TO QUALITY.

Laboratory Excellence Begins with the CAP

Quality and excellence in laboratory medicine is what patients and clinicians expect. The CAP is committed to its members and customers, working with them as they partner with other clinicians to provide accurate test results and ensure high-quality patient care. To deliver on this commitment, the CAP provides a comprehensive range of laboratory quality solutions that help manage the routine and esoteric in laboratory testing.

A multitude of members lead premier laboratory quality solutions, among them accreditation and proficiency testing (PT). These members lend their knowledge and expertise to provide leading-edge science for programs relied on by laboratories in more than 100 countries for daily operations and patient care.

The CAP’s PT program develops innovative programs addressing emerging technologies, ensuring state-of-the-art patient care. It provides PT to more than 22,700 laboratories worldwide. The CAP introduced 22 new programs into its already comprehensive offering, bringing the total to more than 700 PT programs overall.

The Laboratory Accreditation Program, accrediting more than 8,000 laboratories across the globe, assists laboratories in managing the changes in laboratory medicine and technology through self- and on-site inspection. The CAP’s inspection process fosters the exchange of ideas and best practices among pathology and laboratory medicine peers, offering professional development and learning opportunities for all involved. Laboratories enrolled in CAP accreditation seek to do more than check the boxes to meet regulatory requirements—they are committed to quality improvement for the benefit of their patients.

Laboratory Excellence Begins with the CAP

Quality and excellence in laboratory medicine is what patients and clinicians expect. The CAP is committed to its members and customers, working with them as they partner with other clinicians to provide accurate test results and ensure high-quality patient care. To deliver on this commitment, the CAP provides a comprehensive range of laboratory quality solutions that help manage the routine and esoteric in laboratory testing.

A multitude of members lead premier laboratory quality solutions, among them accreditation and proficiency testing (PT). These members lend their knowledge and expertise to provide leading-edge science for programs relied on by laboratories in more than 100 countries for daily operations and patient care.

The CAP’s PT program develops innovative programs addressing emerging technologies, ensuring state-of-the-art patient care. It provides PT to more than 22,700 laboratories worldwide. The CAP introduced 22 new programs into its already comprehensive offering, bringing the total to 722 PT programs overall.

The Laboratory Accreditation Program, accrediting more than 8,000 laboratories across the globe, assists laboratories in managing the changes in laboratory medicine and technology through self- and on-site inspection. The CAP’s inspection process fosters the exchange of ideas and best practices among pathology and laboratory medicine peers, offering professional development and learning opportunities for all involved. Laboratories enrolled in CAP accreditation seek to do more than check the boxes to meet regulatory requirements—they are committed to quality improvement for the benefit of their patients.

Laboratory Excellence Begins with the CAP

Quality and excellence in laboratory medicine is what patients and clinicians expect. The CAP is committed to its members and customers, working with them as they partner with other clinicians to provide accurate test results and ensure high-quality patient care.

To deliver on this commitment, the CAP provides a comprehensive range of laboratory quality solutions that help manage the routine and esoteric in laboratory testing.

A multitude of members lead premier laboratory quality solutions, among them accreditation and proficiency testing (PT). These members lend their knowledge and expertise to provide leading-edge science for programs relied on by laboratories in more than 100 countries for daily operations and patient care.

The CAP’s PT program develops innovative programs addressing emerging technologies, ensuring state-of-the-art patient care. It provides PT to more than 22,700 laboratories worldwide. The CAP introduced 22 new programs into its already comprehensive offering, bringing the total to 722 PT programs overall.

The Laboratory Accreditation Program, accrediting more than 8,000 laboratories across the globe, assists laboratories in managing the changes in laboratory medicine and technology through self- and on-site inspection. The CAP’s inspection process fosters the exchange of ideas and best practices among pathology and laboratory medicine peers, offering professional development and learning opportunities for all involved. Laboratories enrolled in CAP accreditation seek to do more than check the boxes to meet regulatory requirements—they are committed to quality improvement for the benefit of their patients.

Accreditation Checklists Guide Quality Improvement

Laboratory Accreditation Program inspection teams use 21 discipline-specific checklists with specific requirements to guide them as they partner with laboratories on their quality improvement journey. The checklists help laboratories:

  • Maintain compliance with Centers for Medicare & Medicaid Services (CMS) regulations
  • Improve the quality of laboratory services
  • Stay up to date with changes in laboratory medicine best practices

CAP members lead the annual accreditation checklists updates through their work on many accreditation and PT committees. This attention to the checklists is a crucial part of the CAP’s commitment to strengthen quality and excellence in laboratory medicine. Members’ mastery of daily pathology and laboratory medicine practice supplies the leading-edge science and technology in the checklists, benefitting the clinicians and patients who rely so heavily upon accurate laboratory testing.

In the 2019 accreditation checklist edition, the CAP added 130 new requirements and revised approximately 290 requirements, with the most significant changes in the checklist for microbiology, molecular pathology, and biorepository.

In addition to the Laboratory Accreditation Program, the CAP offers the Biorepository, Reproductive, and Forensic accreditation programs. The CAP 15189 program offers the ISO 15189 international quality standard for medical laboratories. This distinct approach complements the Laboratory Accreditation Program by adding the ISO 15189’s process rigor and systems management approach, helping laboratories probe deeper into process control, root cause analysis, and preventive action in their operations.

The CAP’s commitment to laboratories extends beyond quality solutions and includes the development of essential resources, such as cancer protocols, biomarker templates, and evidence-based guidelines. Members lead the development of these resources as they monitor the ever-changing technology landscape.

Accreditation Checklists Guide Quality Improvement

Laboratory Accreditation Program inspection teams use 21 discipline-specific checklists with specific requirements to guide them as they partner with laboratories on their quality improvement journey. The checklists help laboratories:

  • Maintain compliance with Centers for Medicare & Medicaid Services (CMS) regulations
  • Improve the quality of laboratory services
  • Stay up to date with changes in laboratory medicine best practices

CAP members lead the annual accreditation checklists updates through their work on many accreditation and PT committees. This attention to the checklists is a crucial part of the CAP’s commitment to strengthen quality and excellence in laboratory medicine. Members’ mastery of daily pathology and laboratory medicine practice supplies the leading-edge science and technology in the checklists, benefitting the clinicians and patients who rely so heavily upon accurate laboratory testing.

In the 2019 accreditation checklist edition, the CAP added 130 new requirements and revised approximately 290 requirements, with the most significant changes in the checklist for microbiology, molecular pathology, and biorepository.

In addition to the Laboratory Accreditation Program, the CAP offers the Biorepository, Reproductive, and Forensic accreditation programs. The CAP 15189 program offers the ISO 15189 international quality standard for medical laboratories. This distinct approach complements the Laboratory Accreditation Program by adding the ISO 15189’s process rigor and systems management approach, helping laboratories probe deeper into process control, root cause analysis, and preventive action in their operations.

The CAP’s commitment to laboratories extends beyond quality solutions and includes the development of essential resources, such as cancer protocols, biomarker templates, and evidence-based guidelines. Members lead the development of these resources as they monitor the ever-changing technology landscape.

Accreditation Checklists Guide Quality Improvement

Laboratory Accreditation Program inspection teams use 21 discipline-specific checklists with specific requirements to guide them as they partner with laboratories on their quality improvement journey.

The checklists help laboratories:

  • Maintain compliance with Centers for Medicare & Medicaid Services (CMS) regulations
  • Improve the quality of laboratory services
  • Stay up to date with changes in laboratory medicine best practices

CAP members lead the annual accreditation checklists updates through their work on many accreditation and PT committees. This attention to the checklists is a crucial part of the CAP’s commitment to strengthen quality and excellence in laboratory medicine. Members’ mastery of daily pathology and laboratory medicine practice supplies the leading-edge science and technology in the checklists, benefitting the clinicians and patients who rely so heavily upon accurate laboratory testing.

In the 2019 accreditation checklist edition, the CAP added 130 new requirements and revised approximately 290 requirements, with the most significant changes in the checklist for microbiology, molecular pathology, and biorepository.

In addition to the Laboratory Accreditation Program, the CAP offers the Biorepository, Reproductive, and Forensic accreditation programs. The CAP 15189 program offers the ISO 15189 international quality standard for medical laboratories. This distinct approach complements the Laboratory Accreditation Program by adding the ISO 15189’s process rigor and systems management approach, helping laboratories probe deeper into process control, root cause analysis, and preventive action in their operations.

The CAP’s commitment to laboratories extends beyond quality solutions and includes the development of essential resources, such as cancer protocols, biomarker templates, and evidence-based guidelines. Members lead the development of these resources as they monitor the ever-changing technology landscape.

Essential Resources Strengthen Cancer Reporting

In 2019, members of the Cancer and Pathology Electronic Reporting Committees led the release of 98 revised cancer protocols and biomarker templates, in addition to two new generic biopsy and resection templates. Key revisions included World Health Organization Blue Book updates and improvements to lymph node and margin sections, along with a new technical format of the electronic Cancer Checklist (eCC) template files. The new releases provided improved functionality, easier navigation of the data entry form viewer, and an updated eCC file comparison tool enabling users to easily see differences from one release to the next.

More than 6,000 pathologist FTEs are licensed to use the eCC and the CAP electronic Forms and Reporting Module (eFRM) tools for diagnostic cancer reporting in their laboratory information system and workflow.

In addition, the CAP kicked off a new vendor engagement program in 2019 to help validate the implementation of Cancer Protocol content within laboratory information system (LIS) vendor software. The CAP worked closely with five major vendors to test the eCC functionality, helping to ensure that pathologists can efficiently report on their cancer cases no matter which LIS vendor they use in their workflow.

The CAP continued work on grants from the Centers for Disease Control and Prevention and the California Department of Public Health to further address cancer reporting standardization, structure, and transmission using national health information technology (HIT) standards. These initiatives support continued eCC product development, including technical and functional improvements, pathologist and cancer registrar educational activities, and promotion of downstream data usage for quality reporting and surveillance activities.

cancer cell immunotherapy research

Essential Resources Strengthen Cancer Reporting

In 2019, members of the Cancer and Pathology Electronic Reporting Committees led the release of 98 revised cancer protocols and biomarker templates, in addition to two new generic biopsy and resection templates. Key revisions included World Health Organization Blue Book updates and improvements to lymph node and margin sections, along with a new technical format of the electronic Cancer Checklist (eCC) template files. The new releases provided improved functionality, easier navigation of the data entry form viewer, and an updated eCC file comparison tool enabling users to easily see differences from one release to the next.

More than 6,000 pathologist FTEs are licensed to use the eCC and the CAP electronic Forms and Reporting Module (eFRM) tools for diagnostic cancer reporting in their laboratory information system and workflow.

In addition, the CAP kicked off a new vendor engagement program in 2019 to help validate the implementation of Cancer Protocol content within laboratory information system (LIS) vendor software. The CAP worked closely with five major vendors to test the eCC functionality, helping to ensure that pathologists can efficiently report on their cancer cases no matter which LIS vendor they use in their workflow.

The CAP continued work on grants from the Centers for Disease Control and Prevention and the California Department of Public Health to further address cancer reporting standardization, structure, and transmission using national health information technology (HIT) standards. These initiatives support continued eCC product development, including technical and functional improvements, pathologist and cancer registrar educational activities, and promotion of downstream data usage for quality reporting and surveillance activities.

quality_m_cell2x

Essential Resources Strengthen Cancer Reporting

In 2019, members of the Cancer and Pathology Electronic Reporting Committees led the release of 98 revised cancer protocols and biomarker templates, in addition to two new generic biopsy and resection templates.

Key revisions included World Health Organization Blue Book updates and improvements to lymph node and margin sections, along with a new technical format of the electronic Cancer Checklist (eCC) template files. The new releases provided improved functionality, easier navigation of the data entry form viewer, and an updated eCC file comparison tool enabling users to easily see differences from one release to the next.

More than 6,000 pathologist FTEs are licensed to use the eCC and the CAP electronic Forms and Reporting Module (eFRM) tools for diagnostic cancer reporting in their laboratory information system and workflow.

In addition, the CAP kicked off a new vendor engagement program in 2019 to help validate the implementation of Cancer Protocol content within laboratory information system (LIS) vendor software. The CAP worked closely with five major vendors to test the eCC functionality, helping to ensure that pathologists can efficiently report on their cancer cases no matter which LIS vendor they use in their workflow.

The CAP continued work on grants from the Centers for Disease Control and Prevention and the California Department of Public Health to further address cancer reporting standardization, structure, and transmission using national health information technology (HIT) standards. These initiatives support continued eCC product development, including technical and functional improvements, pathologist and cancer registrar educational activities, and promotion of downstream data usage for quality reporting and surveillance activities.

quality_m_cell2x

Evidence-Based Guidelines Drive Excellence in Care

The members of the CAP’s Pathology and Laboratory Quality Center for Evidence-Based Guidelines (the Center) collaborated or partnered with nearly 20 professional societies and patient advocacy organizations. Together, they furthered the specialty by developing evidence-based guidelines and bringing them to the forefront of clinical decision making. Joint efforts such as these ensure that the practice of pathology is fully represented and its practitioners seen as invaluable members of the clinical care team, advancing excellence in patient care.

In 2019, the Center published the “Quantitative Image Analysis of HER2 Immunohistochemistry for Breast Cancer” guideline and hosted four open comment periods for the following guidelines in development:

  • Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/CAP Guideline Update
  • Biomarker Testing for the Diagnosis of Diffuse Gliomas
  • Laboratory Detection and Initial Diagnosis of Monoclonal Gammopathies
  • Validating Whole Slide Imaging for Diagnostic Purposes in Pathology: Guideline Update

Upon publication, the guidelines in progress will further demonstrate the CAP’s ongoing commitment to developing guidelines for the benefit of clinicians and patients alike.

Evidence-Based Guidelines Drive Excellence in Care

The members of the CAP’s Pathology and Laboratory Quality Center for Evidence-Based Guidelines (the Center) collaborated or partnered with nearly 20 professional societies and patient advocacy organizations. Together, they furthered the specialty by developing evidence-based guidelines and bringing them to the forefront of clinical decision making. Joint efforts such as these ensure that the practice of pathology is fully represented and its practitioners seen as invaluable members of the clinical care team, advancing excellence in patient care.

In 2019, the Center published the “Quantitative Image Analysis of HER2 Immunohistochemistry for Breast Cancer” guideline and hosted four open comment periods for the following guidelines in development:

  • Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/CAP Guideline Update
  • Biomarker Testing for the Diagnosis of Diffuse Gliomas
  • Laboratory Detection and Initial Diagnosis of Monoclonal Gammopathies
  • Validating Whole Slide Imaging for Diagnostic Purposes in Pathology: Guideline Update

Upon publication, the guidelines in progress will further demonstrate the CAP’s ongoing commitment to developing guidelines for the benefit of clinicians and patients alike.

Evidence-Based Guidelines Drive Excellence in Care

The members of the CAP’s Pathology and Laboratory Quality Center for Evidence-Based Guidelines (the Center) collaborated or partnered with nearly 20 professional societies and patient advocacy organizations to develop evidence-based guidelines and bring them to the forefront of clinical decision making.

Joint efforts such as these ensure that the practice of pathology is fully represented and its practitioners seen as invaluable members of the clinical care team, advancing excellence in patient care.

In 2019, the Center published the “Quantitative Image Analysis of HER2 Immunohistochemistry for Breast Cancer” guideline and hosted four open comment periods for the following guidelines in development:

  • Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/CAP Guideline Update
  • Biomarker Testing for the Diagnosis of Diffuse Gliomas
  • Laboratory Detection and Initial Diagnosis of Monoclonal Gammopathies
  • Validating Whole Slide Imaging for Diagnostic Purposes in Pathology: Guideline Update

Upon publication, the guidelines in progress will further demonstrate the CAP’s ongoing commitment to developing guidelines for the benefit of clinicians and patients alike.

Technology Advancements Secure Pathology’s Role in Health Care

Council on Scientific Affairs (CSA) committee members lead the analysis of advancements and changes in technologies that will impact pathology and laboratory medicine. As part of the analysis, members determine the best way to communicate and provide resources to assist pathologists in preparing for, understanding, and/or learning how to use new technologies.

In 2019, the CAP began an initial collaboration with the American College of Radiology (ACR) on AI issues. The Informatics Committee led a CAP19 session for the CAP, the ACR, the Association of Pathology Informatics, and the Digital Pathology Association to discuss opportunities for collaboration on AI, machine learning, and structured reporting. The session culminated with an agreement to work collaboratively on machine learning development issues facing both pathologists and radiologists, as well as a pilot to demonstrate the integration of radiology and pathology structured reporting.

Further, the CSA and the Council on Government and Professional Affairs collaborate to track and act upon AI and machine learning regulatory issues. This collaboration ensures that the pathologist’s voice is represented, as these technologies will have broad impact on the specialty.

Technology Advancements Secure Pathology’s Role in Health Care

Council on Scientific Affairs (CSA) committee members lead the analysis of advancements and changes in technologies that will impact pathology and laboratory medicine. As part of the analysis, members determine the best way to communicate and provide resources to assist pathologists in preparing for, understanding, and/or learning how to use new technologies.

In 2019, the CAP began an initial collaboration with the American College of Radiology (ACR) on AI issues. The Informatics Committee led a CAP19 session for the CAP, the ACR, the Association of Pathology Informatics, and the Digital Pathology Association to discuss opportunities for collaboration on AI, machine learning, and structured reporting. The session culminated with an agreement to work collaboratively on machine learning development issues facing both pathologists and radiologists, as well as a pilot to demonstrate the integration of radiology and pathology structured reporting.

Further, the CSA and the Council on Government and Professional Affairs collaborate to track and act upon AI and machine learning regulatory issues. This collaboration ensures that the pathologist’s voice is represented, as these technologies will have broad impact on the specialty.

Technology Advancements Secure Pathology’s Role in Health Care

Council on Scientific Affairs (CSA) committee members lead the analysis of advancements and changes in technologies that will impact pathology and laboratory medicine. As part of the analysis, members determine the best way to communicate and provide resources to assist pathologists in preparing for, understanding, and/or learning how to use new technologies.

In 2019, the CAP began an initial collaboration with the American College of Radiology (ACR) on AI issues. The Informatics Committee led a CAP19 session for the CAP, the ACR, the Association of Pathology Informatics, and the Digital Pathology Association to discuss opportunities for collaboration on AI, machine learning, and structured reporting. The session culminated with an agreement to work collaboratively on machine learning development issues facing both pathologists and radiologists, as well as a pilot to demonstrate the integration of radiology and pathology structured reporting.

Further, the CSA and the Council on Government and Professional Affairs collaborate to track and act upon AI and machine learning regulatory issues. This collaboration ensures that the pathologist’s voice is represented, as these technologies will have broad impact on the specialty.

LIVING OUR QUALITY MISSION

LIVING OUR QUALITY MISSION

LIVING OUR QUALITY MISSION

22,706

laboratories using CAP PT

8,077

CAP-accredited laboratories

1,965

pathologists participating in on-site inspections

1,965

pathologists participating in on-site inspections

8,077

CAP-accredited laboratories

22,706

laboratories using CAP PT